Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.
Koreckij T; Nguyen H; Brown LG; Yu EY; Vessella RL; Corey E; British Journal Of Cancer, 2009, vol. 101, issue 2, p 263, ISSN 15321827. ISBN 15321827.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef